Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Bluerock Homes Trust
BHM
$34.9M
| $85.8K | ﹤0.01% |
4,900
| – | – |
|
3827
EVgo
EVGO
$229M
| $85.6K | ﹤0.01% |
34,940
-37,502
| -52% | -$76.8K |
|
3828
Expensify
EXFY
$245M
| $85K | ﹤0.01% |
57,049
-23,397
| -29% | -$36.9K |
|
|
ESSA
3829
DELISTED
ESSA Bancorp
ESSA
| $84.9K | ﹤0.01% |
4,828
-2,979
| -38% | -$50.5K |
|
3830
Vanguard Morningstar Growth ETF
VUG
$231B
| $84.9K | ﹤0.01% |
1,362
| – | – |
|
|
ZAPP
3831
DELISTED
Zapp Electric Vehicles
ZAPP
| $84.8K | ﹤0.01% |
+41,985
| New | +$104K |
|
3832
MBIA
MBI
$260M
| $84.6K | ﹤0.01% |
15,408
-36,978
| -71% | -$222K |
|
3833
Lyell Immunopharma
LYEL
$360M
| $84.5K | ﹤0.01% |
2,915
-4,412
| -60% | -$210K |
|
3834
Absci
ABSI
$1.51B
| $84.5K | ﹤0.01% |
27,421
-44,690
| -62% | -$207K |
|
3835
Amylyx Pharmaceuticals
AMLX
$2.54B
| $84.1K | ﹤0.01% |
44,253
-62,589
| -59% | -$121K |
|
3836
Greene County Bancorp
GCBC
$589M
| $84.1K | ﹤0.01% |
2,494
-3,922
| -61% | -$117K |
|
3837
CALL
Madrigal Pharmaceuticals
MDGL
$11.8B
| $84K | ﹤0.01% |
300
-8,700
| -97% | -$2.07M |
|
3838
BiomX
PHGE
$1.85M
| $84K | ﹤0.01% |
+1,316
| New | +$88.7K |
|
3839
Capricor Therapeutics
CAPR
$237M
| $83.8K | ﹤0.01% |
+17,572
| New | +$98K |
|
3840
PepGen
PEPG
$197M
| $83.8K | ﹤0.01% |
5,248
-1,755
| -25% | -$25.2K |
|
3841
Primis Financial Corp
FRST
$404M
| $83.6K | ﹤0.01% |
7,981
-7,170
| -47% | -$75.1K |
|
3842
Stem
STEM
$52.7M
| $83.4K | ﹤0.01% |
3,759
-9,209
| -71% | -$270K |
|
3843
Village Super Market
VLGEA
$639M
| $83.3K | ﹤0.01% |
3,156
-3,102
| -50% | -$87.2K |
|
|
NB
3844
NioCorp Developments
NB
$780M
| $83.2K | ﹤0.01% |
48,111
-457
| -0.9% | -$1.06K |
|
3845
AerSale
ASLE
$279M
| $83.1K | ﹤0.01% |
12,007
-17,601
| -59% | -$126K |
|
|
CVLY
3846
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $82.9K | ﹤0.01% |
3,448
-5,705
| -62% | -$126K |
|
3847
ProShares Bitcoin Strategy ETF
BITO
$1.45B
| $82.6K | ﹤0.01% |
3,671
| – | – |
|
3848
Nomad Foods
NOMD
$1.68B
| $82.4K | ﹤0.01% |
+4,999
| New | +$90K |
|
3849
Ituran Location and Control
ITRN
$1.05B
| $82.1K | ﹤0.01% |
3,331
-2,561
| -43% | -$67.9K |
|
3850
Spire Global
SPIR
$555M
| $82K | ﹤0.01% |
+7,563
| New | +$78.2K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.